Elicio Therapeutics, Inc. (ELTX) Q1 2024 Annual Earnings
ELTX·Reported May 15, 2024·Before market open
Diluted EPS came in at $-1.15, missed the $-1.09 consensus by $0.06.
Diluted EPS
$-1.15missed by $0.06
Consensus: $-1.09
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Elicio Therapeutics, Inc.'s Q1 2024 earnings report.
Elicio Therapeutics, Inc. (ELTX) reported Q1 2024 earnings on May 15, 2024 before market open.
Elicio Therapeutics, Inc. reported diluted EPS of $-1.15 for Q1 2024.
EPS missed the consensus estimate of $-1.09 by $0.06.
You can read the 10-K/A periodic report (0001140361-24-022682) directly on SEC EDGAR. The filing index links above go to sec.gov.